FindTrial
Sign In

Efficacy of zinc as an adjuvant therapy in the treatment of severe pneumonia in hospitalised children between 2 months to 5 years of age: A randomised control trial

Efficacy of zinc as an adjuvant therapy in the treatment of severe pneumonia in hospitalised children between 2 months to 5 years of age:randomised controlled trial - No

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090821
Enrollment
41
Registered
2025-07-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J189- Pneumonia, unspecified organism

Interventions

Intervention1: Mudukanagouda: Zinc supplement in treatment of severe Pneumonia in hospitalised children between 2 months to 5 years of age Intervention2: In the treatment of severe pneumonia in hospit

Sponsors

Mudukanagouda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: As per WHO guidelines: Child with severe pneumonia with clinical features of lower chest indrawing, Unable breastfeed, lethargy, convulsions, unconsciousness, severe respiratory distress, central cyanosis

Exclusion criteria

Exclusion criteria: Children with any congenital heart disease, congenital lung disease, Children with aspiration pneumonia, Children with history of wheezing and recurrent chest infection, Children already taking zinc 2 weeks prior to study Children who need mechanical ventilation are excluded from this study

Design outcomes

Primary

MeasureTime frame
Improvement of tachypnea in hours at the time of dischargeTimepoint: Improvement of tachypnea in hours at the time of discharge—

Secondary

MeasureTime frame
Improvement in chest indrawing in hours,Improvement in oxygen saturation in hours,Baseline serum zinc level Duration of Hospitalisation (h)Timepoint: Improvement in chest indrawing in hours,Improvement in oxygen saturation in hours,Baseline serum zinc level Duration of Hospitalisation (h)—

Countries

India

Contacts

Public ContactDr PRAKASH K WARI

Karnataka medical College and research institute hubli

pkwari55@gmail.com9448063128

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026